Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Study of 0.5%, 0.1% & 0.01% Atropine Treatment to Both Eyes In Treatment of Myopia In Children
The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2010 by Singapore National Eye Centre.
Recruitment status was  Active, not recruiting
Study NCT00371124   Information provided by Singapore National Eye Centre

First Received on August 30, 2006.   Last Updated on August 30, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Myopia
More general conditions related to this trial
Eye Diseases
Refractive Errors
Interventions listed in this trial
Atropine Eye drops
Additional drug interventions recognized in this trial
Atropine
More general drug interventions related to this trial
Adjuvants, Anesthesia
Anti-Arrhythmia Agents
Anti-Asthmatic Agents
Autonomic Agents
Bronchodilator Agents
Cardiovascular Agents
Central Nervous System Agents
Cholinergic Agents
Cholinergic Antagonists
Molecular Mechanisms of Pharmacological Action
Muscarinic Antagonists
Mydriatics
Neurotransmitter Agents
Parasympatholytics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
Singapore National Eye Centre


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services